openPR Logo
Press release

Biosimilars Market Analysis, Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts 2026(Sandoz International GmbH, Teva Pharmaceuticals Industries, Amgen Inc)

09-30-2020 01:36 PM CET | Health & Medicine

Press release from: QY Research, Inc

Biosimilars Market Analysis, Size, Application Analysis,

Los Angeles, United State, – – QY Research recently added a research report, Global Biosimilars Market Research Report 2020 to its ever-increasing repository. The research report discusses the future of the global Biosimilars market. It highlights the drivers and restraints and sheds light on the undercurrents defining the threats and opportunities. The research report is projected to provide the readers with a thorough evaluation of factors influencing the global Biosimilars market. To serve the same purpose, analysts have used a SWOT analysis and Porter’s five forces analysis. These evaluations are supported by unbiased opinions of market experts.

The assessment of the global Biosimilars market is determined with mention of global figures and CAGR for the forecast period. Analysts have also included the historic figures for the mentioned segments and the forecast ones to help the readers understand the progress each part of the global Biosimilars market will make in the coming years.

Get PDF template of this report:

https://www.qyresearch.com/index/detail/1411595/global-biosimilars-market

Global Biosimilars Market: Drivers and Restraints

The thorough evaluation of the global Biosimilars market includes a complete explanation of the drivers present in the market. Analysts have studied the investments in research and development, the impact of changing economies, and consumer behaviors to ascertain the factors that will drive the overall market. In addition, analysts have also tried to factor in changes in manufacturing activities and industrial operations that will determine the sales of the products in the global Biosimilars market.

This chapter also explains the possible restraints present in the global Biosimilars market. It assesses the reasons that could hamper the growth of the market. Analysts have evaluated the rising environmental concerns and fluctuating cost of raw materials that is projected to dampen the spirit of the global Biosimilars market. However, analysts have also presented potential opportunities that the players in the global Biosimilars market can bank on. The chapter on drivers, restraints, threats, and opportunities presents a holistic view of the global Biosimilars market.

Key players cited in the report:

Pfizer, Sandoz International GmbH, Teva Pharmaceuticals Industries, Amgen Inc, Biocon, Dr. Reddy’s Laboratories, F. Hoffmann-La Roche, Celltrion, Samsung Bioepis

Global Biosimilars Market: Competitive Landscape

Analysts have thoroughly assessed the competitive landscape present in the global Biosimilars market. The report includes the study of the key players operating in the Biosimilars market. It also details the strategic initiatives that the companies have taken in recent years to keep up with the intensifying competition. In addition, it also includes an evaluation of the financial outlook of these companies, their research and development plans, and their business strategies going forward.

Global Biosimilars Market: Segment Analysis

This chapter focuses on the various segments present in the global Biosimilars market. The report segments the market based on type, application, product, service, and end users. This breakdown allows a granular view of the subject. It helps in understanding the changes in production and overall needs of consumers that are likely to influence these segments.

Global Biosimilars Market by Type Segments:

Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin), Peptides (Glucagon, Calcitonin)

Global Biosimilars Market by Application Segments:

Oncology, Blood Disorders

Global Biosimilars Market: Regional Analysis

The chapter on regional analysis highlights the political scenario in emerging economies and developed nations that are expected to influence the demand and supply dynamics. The regional analysis also helps in ascertaining the shifting needs of the population that have a critical impact on the overall Biosimilars market. Cost of labor, raw materials, and production costs depending on the region have also been factored in this part of the research report.

The Middle East and Africa (GCC Countries and Egypt)
North America (the United States, Mexico, and Canada)
South America (Brazil etc.)
Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)
Enquire Customization In the Report:

https://www.qyresearch.com/customize-request/form/1411595/global-biosimilars-market

Key Questions Answered

The report answers important questions that companies may have when operating in the global Biosimilars market. Some of the questions are given below:

What will be the size of the global Biosimilars market in 2026?
What is the current CAGR of the global Biosimilars market?
Which product is expected to show the highest market growth?
Which application is projected to gain a lion’s share of the global Biosimilars market?
Which region is foretold to create the most number of opportunities in the global Biosimilars market?
Will there be any changes in market competition during the forecast period?
Which are the top players currently operating in the global Biosimilars market?
How will the market situation change in the coming years?
What are the common business tactics adopted by players?
What is the growth outlook of the global Biosimilars market?
Answering such types of questions can be very helpful for players to clear their doubts when implementing their strategies to gain growth in the global Biosimilars market. The report offers a transparent picture of the real situation of the global Biosimilars market so that companies can operate more effectively. It can be customized according to the needs of readers for better understanding of the global Biosimilars market.

Table of Content

Table of Contents 1 Biosimilars Market Overview
1.1 Biosimilars Product Overview
1.2 Biosimilars Market Segment by Type
1.2.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.2 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
1.2.3 Peptides (Glucagon, Calcitonin)
1.3 Global Biosimilars Market Size by Type
1.3.1 Global Biosimilars Sales and Growth by Type
1.3.2 Global Biosimilars Sales and Market Share by Type
1.3.3 Global Biosimilars Revenue and Market Share by Type
1.3.4 Global Biosimilars Price by Type
1.4 North America Biosimilars by Type
1.5 Europe Biosimilars by Type
1.6 South America Biosimilars by Type
1.7 Middle East and Africa Biosimilars by Type 2 Global Biosimilars Market Competition by Company
2.1 Global Biosimilars Sales and Market Share by Company (2014-2019)
2.2 Global Biosimilars Revenue and Share by Company (2014-2019)
2.3 Global Biosimilars Price by Company (2014-2019)
2.4 Global Top Players Biosimilars Manufacturing Base Distribution, Sales Area, Product Types
2.5 Biosimilars Market Competitive Situation and Trends
2.5.1 Biosimilars Market Concentration Rate
2.5.2 Global Biosimilars Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion 3 Biosimilars Company Profiles and Sales Data
3.1 Pfizer
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Biosimilars Product Category, Application and Specification
3.1.3 Pfizer Biosimilars Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Sandoz International GmbH
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Biosimilars Product Category, Application and Specification
3.2.3 Sandoz International GmbH Biosimilars Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Teva Pharmaceuticals Industries
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Biosimilars Product Category, Application and Specification
3.3.3 Teva Pharmaceuticals Industries Biosimilars Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Amgen Inc
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Biosimilars Product Category, Application and Specification
3.4.3 Amgen Inc Biosimilars Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Biocon
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Biosimilars Product Category, Application and Specification
3.5.3 Biocon Biosimilars Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Dr. Reddy’s Laboratories
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Biosimilars Product Category, Application and Specification
3.6.3 Dr. Reddy’s Laboratories Biosimilars Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 F. Hoffmann-La Roche
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Biosimilars Product Category, Application and Specification
3.7.3 F. Hoffmann-La Roche Biosimilars Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Celltrion
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Biosimilars Product Category, Application and Specification
3.8.3 Celltrion Biosimilars Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Samsung Bioepis
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Biosimilars Product Category, Application and Specification
3.9.3 Samsung Bioepis Biosimilars Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview 4 Biosimilars Market Status and Outlook by Regions
4.1 Global Biosimilars Market Status and Outlook by Regions
4.1.1 Global Biosimilars Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Europe
4.1.4 Asia-Pacific
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Biosimilars Sales and Revenue by Regions
4.2.1 Global Biosimilars Sales Market Share by Regions (2014-2019)
4.2.2 Global Biosimilars Revenue Market Share by Regions (2014-2019)
4.2.3 Global Biosimilars Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Biosimilars Sales, Revenue, Price and Gross Margin
4.3.1 North America Biosimilars Sales by Countries
4.3.2 United States
4.3.3 Canada
4.3.4 Mexico
4.4 Europe Biosimilars Sales, Revenue, Price and Gross Margin
4.4.1 Europe Biosimilars Sales by Countries
4.4.2 Germany
4.4.3 France
4.4.4 UK
4.4.5 Italy
4.4.6 Russia
4.5 Asia-Pacific Biosimilars Sales, Revenue, Price and Gross Margin
4.5.1 Asia-Pacific Biosimilars Sales by Regions
4.5.2 China
4.5.3 Japan
4.5.4 South Korea
4.5.5 India
4.5.6 Australia
4.5.7 Indonesia
4.5.8 Thailand
4.5.9 Malaysia
4.5.10 Philippines
4.5.11 Vietnam
4.6 South America Biosimilars Sales, Revenue, Price and Gross Margin

4.6.1 South America Biosimilars Sales by Countries
4.6.2 Brazil
4.7 Middle East and Africa Biosimilars Sales, Revenue, Price and Gross Margin
4.7.1 Middle East and Africa Biosimilars Sales by Countries
4.7.2 Turkey
4.7.3 GCC Countries
4.7.4 Egypt
4.7.5 South Africa 5 Biosimilars Application
5.1 Biosimilars Segment by Application
5.1.1 Oncology
5.1.2 Blood Disorders
5.2 Global Biosimilars Product Segment by Application
5.2.1 Global Biosimilars Sales by Application
5.2.2 Global Biosimilars Sales and Market Share by Application (2014-2019)
5.3 North America Biosimilars by Application
5.4 Europe Biosimilars by Application
5.5 Asia-Pacific Biosimilars by Application
5.6 South America Biosimilars by Application
5.7 Middle East and Africa Biosimilars by Application 6 Global Biosimilars Market Forecast
6.1 Global Biosimilars Sales, Revenue Forecast (2019-2025)
6.1.1 Global Biosimilars Sales and Growth Rate Forecast (2019-2025)
6.1.2 Global Biosimilars Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Biosimilars Forecast by Regions
6.2.1 North America Biosimilars Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Biosimilars Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Biosimilars Sales and Revenue Forecast (2019-2025)
6.2.4 South America Biosimilars Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Biosimilars Sales and Revenue Forecast (2019-2025)
6.3 Biosimilars Forecast by Type
6.3.1 Global Biosimilars Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Growth Forecast
6.3.3 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Growth Forecast
6.4 Biosimilars Forecast by Application
6.4.1 Global Biosimilars Sales Forecast by Application (2019-2025)
6.4.2 Global Biosimilars Forecast in Oncology
6.4.3 Global Biosimilars Forecast in Blood Disorders 7 Biosimilars Upstream Raw Materials
7.1 Biosimilars Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Biosimilars Industrial Chain Analysis 8 Marketing Strategy Analysis, Distributors
8.1 Sales Channel
8.2 Distributors
8.3 Downstream Customers 9 Research Findings and Conclusion 10 Appendix
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

"

Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimilars Market Analysis, Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts 2026(Sandoz International GmbH, Teva Pharmaceuticals Industries, Amgen Inc) here

News-ID: 2147205 • Views: 660

More Releases from QY Research, Inc

COVID-19 Traditional Chinese Medicine Treatment Market To Witness Astonishing Gr …
The global COVID-19 Traditional Chinese Medicine Treatment market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future status of the global COVID-19 Traditional Chinese Medicine Treatment market. The research study comes out as a compilation of useful guidelines for players to secure a position
Valsartan Tablets Market Regional Revenue, Growth And Trends Analysis 2020-2026 …
The global Valsartan Tablets market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future status of the global Valsartan Tablets market. The research study comes out as a compilation of useful guidelines for players to secure a position of strength in the global Valsartan
Hydrocortisone Oral Tablets Market Overview Industry Demand, Development And Gro …
The global Hydrocortisone Oral Tablets market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future status of the global Hydrocortisone Oral Tablets market. The research study comes out as a compilation of useful guidelines for players to secure a position of strength in the
Carisoprodol Tablets Market Regional Revenue, Growth And Trends Analysis 2020-20 …
The global Carisoprodol Tablets market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future status of the global Carisoprodol Tablets market. The research study comes out as a compilation of useful guidelines for players to secure a position of strength in the global Carisoprodol

All 5 Releases


More Releases for Biosimilars

PHASE-XS – Access To Life Changing Biosimilars
Biopharmaceutical is one of the fastest growing industries with addition of numerous biologics that provide novel treatment modalities for life-threatening and rare diseases. Biologics are produced from living organisms through unique manufacturing and purification processes. It includes a wide variety of products such as vaccines, blood, blood components, cells, allergens, genes, tissues, and recombinant proteins that are derived from human, animal or microorganisms by using biotechnological procedures. Some examples for
Global Biosimilars Market Research Report
This report studies the global Biosimilars market status and forecast, categorizes the global Biosimilars market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Pfizer Sandoz International GmbH Teva Pharmaceuticals Industries Amgen Inc Biocon Dr. Reddy’s Laboratories F. Hoffmann-La Roche Celltrion Samsung Bioepis
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Biosimilar is a medicine developed on the original biological reference product. The production process of biopharmaceuticals vary from one manufacturer to another, thus every biosimilar product is unique from the other. Biosimilar manufactures use different culture conditions, master cell lines, purification techniques, and raw materials. This in turn, helps meet the rising prevalence of diabetes due to inadequate healthcare services, rising prevalence of obesity, For instance, According to 2013 American
Humira Biosimilars Clinical Trial Insight
“Humira Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 33 biosimilars version of Humira drug in clinical pipeline. More than 10 of these biosimilars are in Phase-III trials and are expected to be commercially available in next 5-8 years. The patent protection assigned to Humira will expire in 2016 for US and 2018 for European market.
Enbrel Biosimilars Clinical Trial Insight
“Enbrel Biosimilars Clinical Trial Insight” report by PNS Pharma gives comprehensive clinical insight on 36 biosimilars version of Enbrel drug in clinical pipeline. More than 5 of these biosimilars are in Phase-III trials and are expected to be commercially available in next 5-8 years. Currently 5 biosimilar version of Enbrel are commercially available in Iran, Mexico, India, UK and Australia. The patent on Enbrel was originally set to expire on